Abstract
Dydrogesterone, similar to women's natural progesterone, has been used in a wide range of gynecological conditions. Despite its widespread use, dydrogesterone-induced hepatotoxicity and dydrogesterone-induced hemolytic anemia have, to the best of our knowledge, never been reported previously. We describe a case of hepatitis and warm antibody hemolytic anemia due to dydrogesterone.
MeSH terms
-
Acute Disease
-
Adult
-
Anemia, Hemolytic, Autoimmune / chemically induced*
-
Anemia, Hemolytic, Autoimmune / therapy
-
Biopsy, Needle
-
Chemical and Drug Induced Liver Injury / etiology*
-
Chemical and Drug Induced Liver Injury / therapy
-
Dose-Response Relationship, Drug
-
Drug Administration Schedule
-
Dydrogesterone / adverse effects*
-
Dydrogesterone / therapeutic use
-
Female
-
Follow-Up Studies
-
Humans
-
Immunohistochemistry
-
Liver Function Tests
-
Risk Assessment
-
Severity of Illness Index